Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group

Sarah M. Nielsen; Diana M Eccles; Iris L. Romero; Maria  Rossing; Thomas van Overeem Hansen; Amanda Spurdle; Arcangela De Nicolo; Encarna B. Gomez-Garcia; ENIGMA consortium

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group

Sarah M. Nielsen (Medlem af forfattergruppering), Diana M Eccles (Medlem af forfattergruppering), Iris L. Romero (Medlem af forfattergruppering), Maria Rossing (Medlem af forfattergruppering), Thomas van Overeem Hansen (Medlem af forfattergruppering), Amanda Spurdle (Medlem af forfattergruppering), Arcangela De Nicolo (Medlem af forfattergruppering), Encarna B. Gomez-Garcia (Medlem af forfattergruppering), ENIGMA consortium

Afdeling for Genomisk Medicin

28 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	JCO Precision Oncology
Vol/bind	2
Sider (fra-til)	1-42
Antal sider	43
ISSN	2473-4284
Status	Udgivet - 2018

Citationsformater

Nielsen, S. M., Eccles, D. M., Romero, I. L., Rossing, M., van Overeem Hansen, T., Spurdle, A., De Nicolo, A., Gomez-Garcia, E. B., & ENIGMA consortium (2018). Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group. JCO Precision Oncology, 2, 1-42.

Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group. / Nielsen, Sarah M. (Medlem af forfattergruppering); Eccles, Diana M (Medlem af forfattergruppering); Romero, Iris L. (Medlem af forfattergruppering) et al.
I: JCO Precision Oncology, Bind 2, 2018, s. 1-42.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Nielsen, SM, Eccles, DM, Romero, IL, Rossing, M , van Overeem Hansen, T, Spurdle, A, De Nicolo, A, Gomez-Garcia, EB & ENIGMA consortium 2018, 'Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group', JCO Precision Oncology, bind 2, s. 1-42.

Nielsen SM, Eccles DM, Romero IL, Rossing M , van Overeem Hansen T, Spurdle A et al. Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group. JCO Precision Oncology. 2018;2:1-42.

Nielsen, Sarah M. ; Eccles, Diana M ; Romero, Iris L. et al. / Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group. I: JCO Precision Oncology. 2018 ; Bind 2. s. 1-42.

@article{0ef53f6e43b8414e82b3a4367ceab86a,

title = "Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group",

author = "Nielsen, {Sarah M.} and Eccles, {Diana M} and Romero, {Iris L.} and Maria Rossing and {van Overeem Hansen}, Thomas and Amanda Spurdle and {De Nicolo}, Arcangela and Gomez-Garcia, {Encarna B.} and {ENIGMA consortium}",

note = "Member of the Clinical Working Group : Sarah M. Nielsen, Diana M. Eccles, Iris L. Romero, Fahd Al-Mulla, Judith Balma{\~n}a, Michela Biancolella, Rien Blok, Maria Adelaide Caligo, Mariarosaria Calvello, Gabriele Lorenzo Capone, Pietro Cavalli, T.L. Chris Chan, Kathleen B.M. Claes, Laura Cortesi, Fergus J. Couch, Miguel de la Hoya, Simona De Toffol, Orland Diez, Susan M. Domchek, Ros Eeles, Anna Efremidis, Florentia Fostira, David Goldgar, Andreas Hadjisavvas, Thomas v.O. Hansen, Akira Hirasawa, Claude Houdayer, Petra Kleiblova, Sophie Krieger, Conxi L{\'a}zaro, Maria Loizidou, Siranoush Manoukian, Arjen R. Mensenkamp, Setareh Moghadasi, Alvaro N. Monteiro, Luigi Mori, April Morrow, Nadia Naldi, Henriette R. Nielsen, Olufunmilayo I. Olopade, Nicholas S. Pachter, Edenir I. Palmero, Inge S. Pedersen, Maria Piane, Marianna Puzzo, Mark Robson, Maria Rossing, Maria Christina Sini, Angela Solano, Jana Soukupova, Gianluca Tedaldi, Manuel Teixeira, Mads Thomassen, Maria Grazia Tibiletti, Amanda Toland, Therese T{\"o}rngren, Erica Vaccari, Liliana Varesco, Ana Vega, Yvonne Wallis, Barbara Wappenschmidt, Jeffrey Weitzel, Amanda B. Spurdle, Arcangela De Nicolo, and Encarna B. G{\'o}mez-Garc{\'i}a",

year = "2018",

language = "English",

volume = "2",

pages = "1--42",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group

AU - ENIGMA consortium

A2 - Nielsen, Sarah M.

A2 - Eccles, Diana M

A2 - Romero, Iris L.

A2 - Rossing, Maria

A2 - van Overeem Hansen, Thomas

A2 - Spurdle, Amanda

A2 - De Nicolo, Arcangela

A2 - Gomez-Garcia, Encarna B.

N1 - Member of the Clinical Working Group : Sarah M. Nielsen, Diana M. Eccles, Iris L. Romero, Fahd Al-Mulla, Judith Balmaña, Michela Biancolella, Rien Blok, Maria Adelaide Caligo, Mariarosaria Calvello, Gabriele Lorenzo Capone, Pietro Cavalli, T.L. Chris Chan, Kathleen B.M. Claes, Laura Cortesi, Fergus J. Couch, Miguel de la Hoya, Simona De Toffol, Orland Diez, Susan M. Domchek, Ros Eeles, Anna Efremidis, Florentia Fostira, David Goldgar, Andreas Hadjisavvas, Thomas v.O. Hansen, Akira Hirasawa, Claude Houdayer, Petra Kleiblova, Sophie Krieger, Conxi Lázaro, Maria Loizidou, Siranoush Manoukian, Arjen R. Mensenkamp, Setareh Moghadasi, Alvaro N. Monteiro, Luigi Mori, April Morrow, Nadia Naldi, Henriette R. Nielsen, Olufunmilayo I. Olopade, Nicholas S. Pachter, Edenir I. Palmero, Inge S. Pedersen, Maria Piane, Marianna Puzzo, Mark Robson, Maria Rossing, Maria Christina Sini, Angela Solano, Jana Soukupova, Gianluca Tedaldi, Manuel Teixeira, Mads Thomassen, Maria Grazia Tibiletti, Amanda Toland, Therese Törngren, Erica Vaccari, Liliana Varesco, Ana Vega, Yvonne Wallis, Barbara Wappenschmidt, Jeffrey Weitzel, Amanda B. Spurdle, Arcangela De Nicolo, and Encarna B. Gómez-García

PY - 2018

Y1 - 2018

M3 - Journal article

SN - 2473-4284

VL - 2

SP - 1

EP - 42

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -